146 related articles for article (PubMed ID: 37632171)
1. Prescription of sodium valproate to women of childbearing potential in Southern District Mental Health Services in New Zealand.
Corfe-Tan J; McLay L; Mentzel C
Australas Psychiatry; 2023 Dec; 31(6):776-781. PubMed ID: 37632171
[TBL] [Abstract][Full Text] [Related]
2. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
4. Brief intervention reduces prescription of sodium valproate in women of childbearing age.
Goldspink R; Pumipi T; Menkes DB
Australas Psychiatry; 2023 Aug; 31(4):524-527. PubMed ID: 37035997
[TBL] [Abstract][Full Text] [Related]
5. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
Bhakta J; Bainbridge J; Borgelt L
Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
[TBL] [Abstract][Full Text] [Related]
6. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
[TBL] [Abstract][Full Text] [Related]
7. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
8. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
9. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
James L; Barnes TR; Lelliott P; Taylor D; Paton C
J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
[TBL] [Abstract][Full Text] [Related]
10. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
[TBL] [Abstract][Full Text] [Related]
11. Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review.
Gotlib D; Perelstein E; Kurlander J; Zivin K; Riba M; Muzik M
J Clin Psychiatry; 2016 Apr; 77(4):527-34. PubMed ID: 27137421
[TBL] [Abstract][Full Text] [Related]
12. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
13. [Isotretinoin: compliance with recommendations in childbearing women].
Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
[TBL] [Abstract][Full Text] [Related]
14. Prescription of teratogenic medications in United States ambulatory practices.
Schwarz EB; Maselli J; Norton M; Gonzales R
Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
[TBL] [Abstract][Full Text] [Related]
15. Provision of potentially teratogenic medications to female veterans of childbearing age.
Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
[TBL] [Abstract][Full Text] [Related]
16. Sodium valproate and the fetus: a case study and review of the literature.
Smith J; Whitehall J
Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
[TBL] [Abstract][Full Text] [Related]
17. Documentation of contraceptive counseling in female veterans of reproductive age.
Schexnayder CD; King S; Emelogu O
Am J Health Syst Pharm; 2020 Aug; 77(Suppl 3):S71-S77. PubMed ID: 32706019
[TBL] [Abstract][Full Text] [Related]
18. Counseling about medication-induced birth defects with clinical decision support in primary care.
Schwarz EB; Parisi SM; Handler SM; Koren G; Shevchik G; Fischer GS
J Womens Health (Larchmt); 2013 Oct; 22(10):817-24. PubMed ID: 23930947
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications.
Stancil SL; Miller M; Briggs H; Lynch D; Goggin K; Kearns G
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26676050
[TBL] [Abstract][Full Text] [Related]
20. Drug prescribing before and during pregnancy in south west France: a retrolective study.
Crespin S; Bourrel R; Hurault-Delarue C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Drug Saf; 2011 Jul; 34(7):595-604. PubMed ID: 21663335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
